| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,419,819 |
|
|
|
Indirect Value
|
$12,547,761 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$45,967,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -725.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-03-23 |
4 |
S |
$37.65 |
$59,675 |
D/D |
(1,585) |
62,255 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-03-16 |
4 |
S |
$34.25 |
$80,727 |
D/D |
(2,357) |
63,840 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-15 |
4 |
OE |
$16.35 |
$196,200 |
D/D |
12,000 |
65,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-28 |
4 |
AS |
$65.01 |
$1,300,200 |
D/D |
(20,000) |
65,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
66,197 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-29 |
4 |
OE |
$16.35 |
$65,400 |
D/D |
4,000 |
69,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-03 |
4 |
AS |
$70.00 |
$1,400,000 |
D/D |
(20,000) |
69,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-03 |
4 |
OE |
$13.79 |
$341,200 |
D/D |
24,000 |
73,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-19 |
4 |
AS |
$75.00 |
$1,500,000 |
D/D |
(20,000) |
73,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-03-25 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
74,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-27 |
4 |
S |
$84.70 |
$146,616 |
D/D |
(1,731) |
74,478 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-18 |
4 |
S |
$82.66 |
$44,636 |
D/D |
(540) |
76,209 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-10 |
4 |
S |
$81.27 |
$43,236 |
D/D |
(532) |
76,749 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-22 |
4 |
OE |
$16.35 |
$65,400 |
D/D |
4,000 |
77,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, CFO |
• – – |
2011-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
81,478 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-02-22 |
4 |
OE |
$13.79 |
$413,700 |
D/D |
30,000 |
84,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-28 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
85,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-02-14 |
4 |
S |
$90.00 |
$1,800,000 |
D/D |
(20,000) |
86,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-04-01 |
4 |
AS |
$100.00 |
$1,000,000 |
D/D |
(10,000) |
86,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-19 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
93,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-04-01 |
4 |
OE |
$13.79 |
$137,900 |
D/D |
10,000 |
96,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-02-14 |
4 |
OE |
$13.79 |
$378,741 |
D/D |
25,002 |
106,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-04 |
4 |
S |
$153.63 |
$414,801 |
D/D |
(2,700) |
129,775 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-03 |
4 |
S |
$157.14 |
$133,883 |
D/D |
(852) |
132,475 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-01-29 |
4 |
S |
$133.37 |
$132,633 |
D/D |
(994) |
133,327 |
0 |
- |
|
145 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
